Literature DB >> 16694733

SULFAPYRIDINE IN EXPERIMENTAL PNEUMOCOCCIC PNEUMONIA IN THE DOG.

L A Gregg1, M Hamburger, C G Loosli.   

Abstract

Entities:  

Year:  1940        PMID: 16694733      PMCID: PMC434960          DOI: 10.1172/JCI101119

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


× No keyword cloud information.
  7 in total

1.  EXPERIMENTAL PNEUMOCOCCUS LOBAR PNEUMONIA IN THE DOG: II. Pathology.

Authors:  O H Robertson; L T Coggeshall; E E Terrell
Journal:  J Clin Invest       Date:  1933-03       Impact factor: 14.808

2.  EXPERIMENTAL PNEUMOCOCCUS LOBAR PNEUMONIA IN THE DOG: III. Pathogenesis.

Authors:  O H Robertson; L T Coggeshall; E E Terrell
Journal:  J Clin Invest       Date:  1933-03       Impact factor: 14.808

3.  EXPERIMENTAL PNEUMOCOCCUS LOBAR PNEUMONIA IN THE DOG : I. Method of Production and Course of the Disease.

Authors:  E E Terrell; O H Robertson; L T Coggeshall
Journal:  J Clin Invest       Date:  1933-03       Impact factor: 14.808

4.  THE TREATMENT OF PNEUMOCOCCAL PNEUMONIA WITH DAGENAN (M. & B. 693).

Authors:  D Graham; W P Warner; J A Dauphinee; R C Dickson
Journal:  Can Med Assoc J       Date:  1939-04       Impact factor: 8.262

5.  THE TREATMENT OF PNEUMOCOCCIC PNEUMONIA WITH SULFAPYRIDINE.

Authors:  J C Meakins; F R Hanson
Journal:  Can Med Assoc J       Date:  1939-04       Impact factor: 8.262

6.  COMPARATIVE CHEMOTHERAPY IN EXPERIMENTAL PNEUMOCOCCAL INFECTIONS.

Authors:  P H Greey; D B Maclaren; C C Lucas
Journal:  Can Med Assoc J       Date:  1939-04       Impact factor: 8.262

7.  THE DETERMINATION OF SULFANILAMIDE.

Authors:  E K Marshall; J T Litchfield
Journal:  Science       Date:  1938-07-22       Impact factor: 47.728

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.